LianMedical LIANY
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 22.28% | 17.80% | 34.38% | -- | -- |
| Total Depreciation and Amortization | 38.89% | 57.47% | 45.07% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.02% | -116.92% | -95.88% | -- | -- |
| Change in Net Operating Assets | 291.30% | 110.66% | 105.40% | -- | -- |
| Cash from Operations | 15.50% | 31.28% | 40.78% | -- | -- |
| Capital Expenditure | 80.65% | 20.09% | -20.44% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 138.32% | 118.49% | 120.96% | -- | -- |
| Cash from Investing | 137.73% | 117.72% | 120.19% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -99.46% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -100.00% | -99.45% | -- | -- |
| Foreign Exchange rate Adjustments | 53.82% | -62.73% | -431.25% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.27% | -512.06% | 39.79% | -- | -- |